DUBLIN, Ohio, Nov. 14, 2017 — Cardinal Health (NYSE: CAH) today announced that it has signed a definitive agreement to sell its Cardinal Health China business to Shanghai Pharmaceuticals Holding Co., Ltd. (“Shanghai Pharma”) for $1.2 billion.
( read original story …)